Visual impairment: FDA reporting patterns
121,394 FDA FAERS reports mention Visual impairment. 70,463 reports have a serious outcome flag.
Medicines named as suspect
- Insulin Glargine: 7,084 reports
- Insulin Lispro: 5,168 reports
- Adalimumab: 4,787 reports
- Dupilumab: 3,628 reports
- Etanercept: 3,486 reports
- Natalizumab: 2,718 reports
- Fingolimod: 2,692 reports
- Pregabalin: 2,346 reports
- Interferon Beta-1a: 2,274 reports
- Acetaminophen: 2,217 reports
- Aflibercept: 1,972 reports
- Valsartan: 1,924 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.